Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Research into meningococcal B disease

The first approved vaccine represents a major success for meningococcal B research efforts

- PMLiVE

Accelerating drug development by harnessing technology

The pressure is on for biopharma to radically improve the drug development model

- PMLiVE

EASD 2013: Novo Nordisk’s diabetes combination IDegLira impresses in study

Mix of Tresiba and Victoza helps 81 per cent achieve blood sugar target in phase III

- PMLiVE

Mixed news for Lilly on cancer hope ramucirumab

Fails in phase III for breast cancer but better results for stomach cancer

Keith Webber leaves FDA for Perrigo

Switches regulatory agency for biopharma company

- PMLiVE

Boehringer’s oncology unit scores first EU approval

Giotrif given green light for non-small cell lung cancer

- PMLiVE

Primed: changing behaviours by communicating with the subconscious

Priming an audience by changing the default option

Sanofi reception

EASD 2013: Sanofi prepared for biosimilar threat to Lantus

Next generation insulin U300 set to launch at time of patent expiration

- PMLiVE

EASD 2013: Sanofi justifies decision to withdraw US filing for Lyxumia

Takes issue with FDA's narrow risk-benefit focus

- PMLiVE

Boehringer launches integrated Hispanic diabetes campaign

Creative development overseen Miami-based agency Republica

- PMLiVE

Sarah Verhoeff joins the board at Pan

UK advertising agency promotes its associate director

- PMLiVE

Merck Serono puts faith in lung cancer candidate

Continues tecemotide development despite underwhelming phase III results

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links